Investment Summary

HealthpointCapital and EQT Life Sciences Invest In IlluminOss

On May 1, 2020, private equity firm HealthpointCapital and growth capital firm EQT Life Sciences invested in medical products company IlluminOss

Investment Highlights
  • This is HealthpointCapital’s 8th and EQT Life Sciences’ 12th transaction in the Medical Products sector.
  • This is HealthpointCapital’s 8th and EQT Life Sciences’ 5th transaction in the United States.
  • This is HealthpointCapital’s 1st and EQT Life Sciences’ 1st transaction in Rhode Island.

Investment Summary

Date 2020-05-01
Target IlluminOss
Sector Medical Products
Investor(s) HealthpointCapital
EQT Life Sciences
Deal Type Stake Purchase
Advisor(s) GreenbergTraurig (Legal)

Target

IlluminOss

East Providence, Rhode Island, United States
website
IlluminOss is a commercial stage medical device company focused on designing, developing, and marketing orthopedic fracture repair and stabilization products that leverage its proprietary system. IlluminOss was founded in 2007 and is based in East Providence, Rhode Island.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor
DESCRIPTION

HealthpointCapital is a specialist private equity firm focused exclusively on investments in businesses serving the musculoskeletal industry. Specifically, HealthPoint looks for opportunities within the orthopedic and dental device industries. Prospective companies typically possesses proven technologies and demonstrate strong growth potential. HealthpointCapital is based in New York City.


DEAL STATS #
Overall 9 of 10
Sector (Medical Products) 8 of 9
Type (Stake Purchase) 1 of 1
State (Rhode Island) 1 of 1
Country (United States) 8 of 9
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-14 CrossRoads Extremity Systems

Memphis, Tennessee, United States

CrossRoads Extremity Systems is a provider of procedure-specific and sterile-packed implants and instrumentation for foot & ankle fixation. CrossRoads leverages this technology in a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for both lower and upper extremity indications. CrossRoads Extremity Systems was founded in 2014 and is based in Memphis, Tennessee.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-10 SteriCUBE

United States

SteriCUBE is a patented, environmentally friendly technology for simultaneous sterilization of instrument-holding trays. These trays are utilized to organize and protect the numerous instruments required in common orthopaedic and cardiac surgeries.

Buy -
Investor

EQT Life Sciences

website


Category Growth Capital Firm
Founded 1987
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION


DEAL STATS #
Overall 28 of 46
Sector (Medical Products) 12 of 14
Type (Stake Purchase) 2 of 2
State (Rhode Island) 1 of 1
Country (United States) 5 of 11
Year (2020) 3 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-30 Kiadis Pharma

Amsterdam, Netherlands

Kiadis Pharma is a clinical stage biopharmaceutical company pioneering a proprietary cell-based, personalized therapy for patients with blood cancers and related disorders, an area of significant unmet medical need.Kiadis Pharma’s unique and powerful platform technology has led to an initial experimental product, ATIR™, which has already been clinically tested on sixty patients. Kiadis Pharma is based in Amsterdam, Netherlands.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-23 OneProjects

Dublin , Ireland

OneProjects is a medical device company specialising in cardiac imaging innovations and operates at the intersection of hardware, software and data science. OneProjects was founded in 2017 and is based in Dublin, Ireland.

Buy -